A STUDY OF CHEMOTHERAPY DECREASED THE RISK OF DYING FROM COLON CANCER BY ABOUT 30%. AND WAS 95% SURE THAT THE EXPECTED RANGE OF BENEFIT WAS BETWEEN 10% AND 50% (59585)    LAB LOINC COMPONENT (95.31)